Dr Angela Wilkinson Consultant Physician February 2020 The H@H - - PowerPoint PPT Presentation

dr angela wilkinson consultant physician
SMART_READER_LITE
LIVE PREVIEW

Dr Angela Wilkinson Consultant Physician February 2020 The H@H - - PowerPoint PPT Presentation

Dr Angela Wilkinson Consultant Physician February 2020 The H@H teams Rolled out over 3 localities commenced April 2012 Glenrothes & North East Kirkcaldy & Levenmouth Dunfermline & West ICASS (Integrated Community Assessment


slide-1
SLIDE 1

Dr Angela Wilkinson Consultant Physician

February 2020

slide-2
SLIDE 2

The H@H teams

Rolled out over 3 localities –commenced April 2012

Glenrothes & North East Kirkcaldy & Levenmouth Dunfermline & West

slide-3
SLIDE 3

ICASS (Integrated Community Assessment & Support Service)

  • A SINGLE Single Point of Access (SPOA)
  • Co-located offices
  • H@H
  • ICT (Intermediate Care Team)
  • CRT (Community Rehab Team)
  • Community PT
  • Day Hospital / Hubs
  • High Health Gain/Complex Care Mx
  • DPDS (dementia support)
  • Marie Curie
  • Day Hospital/Day Care
  • Specialist Nurse

practitioner

  • Community rehab team
  • Community mental health

team

  • Home Care Re-ablement
  • Community Intermediate

Care teams

  • District Nurse
  • Home care
  • Anticipatory care
  • Self care
  • Tele-care and health
  • Respite care
  • Support for Carers
  • Voluntary organisations
  • Social Enterprises
  • Palliative Care

VIRTUAL WARD

  • Geriatrician
  • Specialist

Nurse consultant

  • GP with

specialist interest

S P O A

slide-4
SLIDE 4

Each H@H Team

 Consultant Geriatrician  Band 7 team lead ( 1 West + 1 East)  CdF or GPST  FY2  Nurses

 Band 7 Trainee ANPs x2  Band 6 NPs x6  Band 5 Nurses x3  Band 3 Healthcare Support Workers x4

 Admin support  AHPs  Pharmacy input

slide-5
SLIDE 5

What can/can’t we do?

Can do:

CANNOT do:

 IV furosemide  Scut furosemide  IV antibiotics (max TDS dosing)  Scut fluids / IV fluid ‘bolus’ / combo (max feasible is 2l in 24hr )  Patient obs TDS max  Blood tests once/day  IV Pamidronate / zolendronate  Use midlines (can’t insert them)  Syringe drivers / end of life care  Low dose oxygen (2L or use SHOOF)  RCC transfusion  Continuous IVI  Vancomycin / QDS IV Abx regimes  QDS visits  Magnesium infusions  IV Digoxin (needs cardiac monitor)  Accurate urine output monitoring is tricky at home/NH!

slide-6
SLIDE 6

An expanding service.....

End year 2012 2013 2014 2015 2016 2017 2018 2019 TOTAL End 2015 Admissions to H@H / YEAR 232 768 1571 1839 2113 2020 1886 1790 12,219

~150 patients ‘admitted’ to H@H per month in 2019

slide-7
SLIDE 7

14 15 15 11 10 8 5 8 8 12 8 11 10 11 8 10 11 12 12 12 12 14 14 3 19 13 19 19 4 16 20 21 25 26 26 24 26 21 12 22 20 14 18 14 14 5 10 15 20 25 30 35 40 Number of Patient's on Caseload

H@H - January 2019

East Division: Patient's West Division: Patient's

slide-8
SLIDE 8

25 30 35 40 45 50 55 60 65 AVERAGE WEEKLY referrals Q1 (2017) to Q2 (2019)

AVERAGE WEEKLY referral (% per quarter) GP vs S/D

GP % SD %

slide-9
SLIDE 9

9.1 10.6 9.5 7.6 8.0 7.2 7.0 10.3 10.3 6.2 5.7 6.3 7.2 6.8 5.4 5.9 5.9 6.3 5.6 0.0 2.0 4.0 6.0 8.0 10.0 12.0 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 Q4 2017 Q1 2018 Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Days Yearly Quarters

Quarterly Average Length of Stay

H@H D&WF H@H GNEF H@H K&L Fife Average

slide-10
SLIDE 10

15.0% 17.2% 16.7% 15.7% 16.1% 15.6% 14.8% 13.6% 13.6% 13.4% 10.8% 8.6% 14.1% 21.6% 16.3% 17.9% 18.7% 9.0% 12.3% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017 Q2 2017 Q3 2017 Q4 2017 Q1 2018 Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Percentage Yearly Quarters

Fife H@H Rate of Re-admissions Per Quarter - Q1 2015 to Q3 2019

slide-11
SLIDE 11

Transfers to acute from H@H

0% 2% 4% 6% 8% 10% 12% 14% Q1 2019 Q2 2019 Q3 2019 Q4 2019 Quarterly transfer rate to acute hospital %

slide-12
SLIDE 12

My ACP

slide-13
SLIDE 13

THE NOMAD NIGHTMARE

THE PATIENT FEEDBACK